Natural History of Sickle Cell Disease
NCT00081523 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500
Last updated 2026-05-22
Summary
This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center.
Conditions
- Pain Crisis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Swee Lay Thein, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 2 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-04-29
Countries
- United States
Study Locations
More Related Trials
-
N-Acetylcysteine in Patients With Sickle Cell Disease
NCT01849016 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Pain in Sickle Cell Disease
NCT06139510 ·Status: RECRUITING ·Phase: NA
-
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Heart Disease in Sickle Cell Anemia
NCT00113152 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Living With Sickle Cell Disease in the COVID-19 Pandemic
NCT04417673 ·Status: COMPLETED
-
Genetics and Pain Severity in Sickle Cell Disease
NCT01441141 ·Status: COMPLETED
-
Blood Flow and Pain Crises in People With Sickle Cell Disease
NCT01568710 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biological Markers in Children With Sickle Cell Disease
NCT04839159 ·Status: UNKNOWN ·Phase: NA
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
NCT02225132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
NCT03380351 ·Status: COMPLETED
-
A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
NCT04166526 ·Status: RECRUITING
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease
NCT01522547 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
NCT07083531 ·Status: RECRUITING
-
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1
-
Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
NCT02394431 ·Status: COMPLETED
-
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
NCT02987725 ·Status: COMPLETED ·Phase: NA
-
Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
NCT04388241 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Anemia WE CARE
NCT03716726 ·Status: COMPLETED ·Phase: NA